Abstract
Objective: In the present work, we report for the first time the therapeutic potential of talazoparib (BMN 673)-SLNs for the treatment of BRCA1 deficient Triple Negative Breast Cancer (TNBC). BMN 673-SLNs were produced by hot-homogenization technique and then characterized.
Methods: The cytotoxic and apoptotic effects of BMN 673-SLNs compared with BMN 673 were determined on HCC1937BRCA1-/-, HCC1937-R resistant TNBC and MCF-10A control cell lines. BMN 673- SLNs were found to have reduced particle size (219.5 ± 1.45 nm) and thus more stable (-28.4 ± 2.52 mV) than BMN 673 (1652 ± 2.46 nm and -18.6 ± 0.45 mV) at 4°C.
Results: In vitro cell line studies demonstrated that BMN 673-SLNs showed significant cytotoxic effects on HCC1937 (29.8%) and HCC1937-R cells (35.7%) at 10 nM for 12 days compared with BMN 673 (HCC1937 cells: 34.0% and HCC1937-R cells: 93.8% at 10 nM for 12 days) (p<0.05). Additionally, BMN 673-SLNs (40.1%) reduced the toxicity of BMN 673 (53.1%) on MCF-10A control cells thanks to unique physical properties.
Conclusion: The apoptotic rates in the 10 nM BMN 673-SLNs treatment (88.78% and 85.56%) for 12 days were significantly higher than those in 10 nM BMN 673 (82.6% and 25.86%) for 12 days in HCC1937 and HCC1937-R cells, respectively (p<0.01). Furthermore, these effects were consistent with the findings of colony formation, wound healing and calcein accumulation analysis. In conclusion, the therapeutic potential of BMN 673-SLNs provides a promising chemotherapeutic strategy for the treatment of drugresistant TNBC.
Keywords: Triple Negative Breast Cancer (TNBC), PARP inhibitors, Talazoparib (BMN 673), Solid Lipid Nanoparticles (SLNs), Apoptosis, cytotoxic effects.
[http://dx.doi.org/10.1016/j.ejca.2008.09.034] [PMID: 19008097]
[http://dx.doi.org/10.1016/S1548-5315(11)70394-1]
[http://dx.doi.org/10.1007/s40265-013-0091-6] [PMID: 23842749]
[http://dx.doi.org/10.1309/AJCPQN8GZ8SILKGN] [PMID: 24619745]
[http://dx.doi.org/10.1172/JCI45014] [PMID: 21633166]
[http://dx.doi.org/10.1158/1078-0432.CCR-13-0583] [PMID: 24536073]
[http://dx.doi.org/10.1016/j.bbacli.2015.03.003] [PMID: 26676166]
[http://dx.doi.org/10.1186/1756-8722-3-42] [PMID: 20979652]
[http://dx.doi.org/10.1016/j.molonc.2010.04.006] [PMID: 20537966]
[http://dx.doi.org/10.3389/fonc.2014.00019] [PMID: 24579064]
[http://dx.doi.org/10.1093/annonc/mds196] [PMID: 23012305]
[http://dx.doi.org/10.1146/annurev-med-050913-022545] [PMID: 25341009]
[http://dx.doi.org/10.1016/j.coph.2008.06.016] [PMID: 18644251]
[http://dx.doi.org/10.4161/cc.10.8.15273] [PMID: 21487248]
[http://dx.doi.org/10.1038/nature03445] [PMID: 15829967]
[http://dx.doi.org/10.1016/j.bcp.2012.03.018] [PMID: 22469522]
[http://dx.doi.org/10.1038/nrclinonc.2014.163] [PMID: 25286972]
[http://dx.doi.org/10.1111/apm.12836] [PMID: 29696717]
[http://dx.doi.org/10.1158/1078-0432.CCR-13-1391] [PMID: 23881923]
[http://dx.doi.org/10.1200/jco.2013.31.15_suppl.2580]
[http://dx.doi.org/10.1200/jco.2013.31.15_suppl.2580]
[http://dx.doi.org/10.1038/onc.2013.311] [PMID: 23934192]
[http://dx.doi.org/10.1158/1535-7163.MCT-13-0803] [PMID: 24356813]
[http://dx.doi.org/10.1158/0008-5472.CAN-12-2753] [PMID: 23118055]
[http://dx.doi.org/10.18632/oncotarget.6287] [PMID: 26539646]
[http://dx.doi.org/10.1016/j.bbrc.2015.05.083] [PMID: 26047697]
[http://dx.doi.org/10.1371/journal.pone.0100041] [PMID: 24927325]
[http://dx.doi.org/10.1021/acs.jmedchem.5b01498] [PMID: 26652717]
[http://dx.doi.org/10.1158/2159-8290.CD-16-1250] [PMID: 28242752]
[http://dx.doi.org/10.1158/1078-0432.CCR-13-1975] [PMID: 24077350]
[http://dx.doi.org/10.1371/journal.pone.0152584] [PMID: 27055253]
[http://dx.doi.org/10.18632/oncotarget.10720] [PMID: 27447864]
[http://dx.doi.org/10.18632/oncotarget.12266] [PMID: 27708213]
[http://dx.doi.org/10.1016/S0939-6411(00)00087-4] [PMID: 10840199]
[http://dx.doi.org/10.1201/9781420008449.ch14]
[http://dx.doi.org/10.15171/apb.2015.043] [PMID: 26504751]
[http://dx.doi.org/10.1016/j.msec.2016.05.119] [PMID: 27524099]
[http://dx.doi.org/dc.doi.org/10.1007/s11095-018-2502-6] [PMID: 30255456]
[http://dx.doi.org/10.1158/0008-5472.CAN-09-4716] [PMID: 20551068]
[http://dx.doi.org/10.1073/pnas.1305170110] [PMID: 24085845]
[http://dx.doi.org/10.1002/jbt.22286] [PMID: 30672063]
[http://dx.doi.org/10.1016/j.saa.2018.02.025] [PMID: 29454253]
[http://dx.doi.org/10.1016/j.molstruc.2018.08.061]
[http://dx.doi.org/10.1016/j.saa.2018.02.060] [PMID: 29550657]
[http://dx.doi.org/10.1016/j.vacuum.2018.10.066]
[http://dx.doi.org/10.1016/0005-2736(94)90190-2] [PMID: 7909692]
[http://dx.doi.org/10.1371/journal.pone.0190629] [PMID: 29342177]
[http://dx.doi.org/10.3892/ol.2016.4596] [PMID: 27347092]
[http://dx.doi.org/10.1016/j.canlet.2016.05.023] [PMID: 27235607]
[http://dx.doi.org/10.4172/2157-7439.1000378]
[http://dx.doi.org/10.1038/nrd4363] [PMID: 25103255]
[http://dx.doi.org/10.1038/nbt.3330] [PMID: 26348965]
[http://dx.doi.org/10.1007/s40097-014-0112-3]
[http://dx.doi.org/10.1155/2015/846743] [PMID: 25685560]
[http://dx.doi.org/10.1039/C4NR07102F] [PMID: 25584654]
[http://dx.doi.org/10.1158/1535-7163.MCT-16-0740] [PMID: 28500233]
[http://dx.doi.org/10.1111/liv.12586] [PMID: 24821649]
[http://dx.doi.org/10.4314/tjpr.v12i2.19]
[http://dx.doi.org/10.1016/j.colsurfb.2010.12.024] [PMID: 21242064]
[http://dx.doi.org/10.1016/j.ajps.2014.05.005]
[http://dx.doi.org/10.15171/apb.2016.021] [PMID: 27478775]
[http://dx.doi.org/10.1038/s41598-017-07617-7] [PMID: 28790402]
[http://dx.doi.org/10.1016/j.jconrel.2005.02.028] [PMID: 15921775]
[http://dx.doi.org/10.1016/j.biomaterials.2007.01.014] [PMID: 17257668]
[http://dx.doi.org/10.1016/j.ejps.2009.04.008] [PMID: 19406231]
[http://dx.doi.org/10.1016/j.biomaterials.2008.09.014] [PMID: 18851881]
[http://dx.doi.org/10.1016/j.nano.2009.12.006] [PMID: 20060074]
[http://dx.doi.org/10.1016/j.biopha.2014.01.004] [PMID: 24560352]
[http://dx.doi.org/10.1208/s12249-016-0505-3] [PMID: 26975870]
[http://dx.doi.org/10.1080/02652048.2016.1202342] [PMID: 27358106]
[http://dx.doi.org/10.1016/j.jphotobiol.2016.10.019] [PMID: 27816641]
[http://dx.doi.org/10.22159/ijpps.2016v8s2.15220]
[http://dx.doi.org/10.1016/j.msec.2013.07.047] [PMID: 24094190]
[http://dx.doi.org/10.1016/j.ejps.2018.04.040] [PMID: 29719240]
[http://dx.doi.org/10.1080/17458080.2015.1038660]
[http://dx.doi.org/10.1016/j.ijpharm.2007.07.012] [PMID: 17714896]
[http://dx.doi.org/10.1016/j.ijpharm.2010.07.021] [PMID: 20655375]
[http://dx.doi.org/10.1016/j.ijpharm.2009.10.011] [PMID: 19833178]
[http://dx.doi.org/10.4333/KPS.2011.41.6.381]
[http://dx.doi.org/10.1016/j.ejpb.2011.02.012] [PMID: 21352915]
[http://dx.doi.org/10.1109/EHB.2017.7995390]